BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020;53:425-435. [PMID: 32414646 DOI: 10.1016/j.jmii.2020.04.015] [Cited by in Crossref: 184] [Cited by in F6Publishing: 174] [Article Influence: 92.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramezankhani R, Solhi R, Chai YC, Vosough M, Verfaillie C. Organoid and microfluidics-based platforms for drug screening in COVID-19. Drug Discov Today 2021:S1359-6446(21)00565-1. [PMID: 34954328 DOI: 10.1016/j.drudis.2021.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ali F, Fang HL, Shah FA, Muhammad SA, Khan A, Li S. Reprofiling analysis of FDA approved drugs with upregulated differential expression genes found in hypertension. Informatics in Medicine Unlocked 2022;29:100895. [DOI: 10.1016/j.imu.2022.100895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin 2020;41:1539-46. [PMID: 33110240 DOI: 10.1038/s41401-020-00554-8] [Cited by in Crossref: 78] [Cited by in F6Publishing: 51] [Article Influence: 39.0] [Reference Citation Analysis]
4 Wang S, Zhang Q, Wang P, Ye H, Jing X, Zhang Z, Zhu S, Luo T, Zheng Z. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. Open Med (Wars) 2021;16:367-74. [PMID: 33869774 DOI: 10.1515/med-2021-0225] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Suryamohan K, Diwanji D, Stawiski EW, Gupta R, Miersch S, Liu J, Chen C, Jiang YP, Fellouse FA, Sathirapongsasuti JF, Albers PK, Deepak T, Saberianfar R, Ratan A, Washburn G, Mis M, Santhosh D, Somasekar S, Hiranjith GH, Vargas D, Mohan S, Phalke S, Kuriakose B, Antony A, Ustav M Jr, Schuster SC, Sidhu S, Junutula JR, Jura N, Seshagiri S. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun Biol 2021;4:475. [PMID: 33846513 DOI: 10.1038/s42003-021-02030-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Morris CP, Luo CH, Amadi A, Schwartz M, Gallagher N, Ray SC, Pekosz A, Mostafa HH. An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern. Clin Infect Dis 2021:ciab636. [PMID: 34272947 DOI: 10.1093/cid/ciab636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Silva-Filho JC, Melo CGF, Oliveira JL. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses 2020;144:110155. [PMID: 33254482 DOI: 10.1016/j.mehy.2020.110155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
8 Dolatshahi M, Sabahi M, Aarabi MH. Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration. Mol Neurobiol 2021;58:2379-94. [PMID: 33417221 DOI: 10.1007/s12035-020-02236-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
9 Morris NH, Elneil S, Morris D, Ellis P, Arulkumaran S. Occupational risk prevention, education and support in black, Asian and ethnic minority health worker in the COVID-19 pandemic. Journal of Patient Safety and Risk Management 2020;25:205-9. [DOI: 10.1177/2516043520946650] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med 2020;58:1415-22. [PMID: 32598305 DOI: 10.1515/cclm-2020-0727] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
11 Berger MM, Hackett PH, Bärtsch P. No Relevant Analogy Between COVID-19 and Acute Mountain Sickness. High Alt Med Biol 2020;21:315-8. [PMID: 32970479 DOI: 10.1089/ham.2020.0147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zubiaur P, Koller D, Saiz-Rodríguez M, Navares-Gómez M, Abad-Santos F. Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clin Transl Sci 2020;13:1023-33. [PMID: 32936528 DOI: 10.1111/cts.12866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Mol Ther Methods Clin Dev 2020;18:321-7. [PMID: 32665962 DOI: 10.1016/j.omtm.2020.06.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
14 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Kashyap D, Jakhmola S, Tiwari D, Kumar R, Moorthy NSHN, Elangovan M, Brás NF, Jha HC. Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study. J Biomol Struct Dyn 2021;:1-22. [PMID: 34225565 DOI: 10.1080/07391102.2021.1947384] [Reference Citation Analysis]
16 Hu S, Buser E, Arredondo J, Relyea D, Santos Rocha C, Dandekar S. Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/AIDS. Front Microbiol 2022;13:879152. [PMID: 35495669 DOI: 10.3389/fmicb.2022.879152] [Reference Citation Analysis]
17 Devaux CA, Pinault L, Delerce J, Raoult D, Levasseur A, Frutos R. Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution. Front Microbiol 2021;12:675528. [PMID: 34616371 DOI: 10.3389/fmicb.2021.675528] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Steffes LC, Cornfield DN. Coronavirus disease 2019 respiratory disease in children: clinical presentation and pathophysiology. Curr Opin Pediatr 2021;33:302-10. [PMID: 33938476 DOI: 10.1097/MOP.0000000000001013] [Reference Citation Analysis]
19 Moreno-P O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, Andres M, Garcia-Navarro M, Ruiz-Torregrosa P, Boix V, Gil J, Merino E; COVID19-ALC Research Group. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis 2020;100:449-54. [PMID: 32950739 DOI: 10.1016/j.ijid.2020.09.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
20 Guijarro C, Pérez-Fernández E, González-Piñeiro B, Meléndez V, Goyanes MJ, Renilla ME, Casas ML, Sastre I, Velasco M; Alcorcón COVID Investigators. Differential risk for COVID-19 in the first wave of the disease among Spaniards and migrants from different areas of the world living in Spain. Rev Clin Esp (Barc) 2021;221:264-73. [PMID: 33998512 DOI: 10.1016/j.rceng.2020.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne) 2021;8:640073. [PMID: 33681266 DOI: 10.3389/fmed.2021.640073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
22 Nassar A, Ibrahim IM, Amin FG, Magdy M, Elgharib AM, Azzam EB, Nasser F, Yousry K, Shamkh IM, Mahdy SM, Elfiky AA. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses. Molecules 2021;26:6455. [PMID: 34770863 DOI: 10.3390/molecules26216455] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Heidari Nia M, Rokni M, Mirinejad S, Kargar M, Rahdar S, Sargazi S, Sarhadi M, Saravani R. Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses. J Med Virol 2021. [PMID: 34821383 DOI: 10.1002/jmv.27477] [Reference Citation Analysis]
24 Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med 2021;9:863-72. [PMID: 34126053 DOI: 10.1016/S2213-2600(21)00214-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Rodrigues R, Costa de Oliveira S. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review. Microorganisms 2021;9:1692. [PMID: 34442770 DOI: 10.3390/microorganisms9081692] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hensel J, McAndrews KM, McGrail DJ, Dowlatshahi DP, LeBleu VS, Kalluri R. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses. Sci Rep. 2020;10:18377. [PMID: 33110184 DOI: 10.1038/s41598-020-75491-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
27 Al-Zaidan L, Mestiri S, Raza A, Merhi M, Inchakalody VP, Fernandes Q, Taib N, Uddin S, Dermime S. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Tumour Biol 2021;43:177-96. [PMID: 34420993 DOI: 10.3233/TUB-200084] [Reference Citation Analysis]
28 Perico L, Benigni A, Remuzzi G. Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic. Curr Opin Nephrol Hypertens 2021;30:252-63. [PMID: 33395036 DOI: 10.1097/MNH.0000000000000692] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Stelzer-Braid S, Walker GJ, Aggarwal A, Isaacs SR, Yeang M, Naing Z, Ospina Stella A, Turville SG, Rawlinson WD. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes. Pathology 2020;52:760-3. [PMID: 33131800 DOI: 10.1016/j.pathol.2020.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Lite C, Ahmed SSSJ, Juliet M, Freddy AJ. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host. Pathog Dis 2021;79:ftab005. [PMID: 33469663 DOI: 10.1093/femspd/ftab005] [Reference Citation Analysis]
31 Vianello A, Del Turco S, Babboni S, Silvestrini B, Ragusa R, Caselli C, Melani L, Fanucci L, Basta G. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? Biomedicines 2021;9:710. [PMID: 34201505 DOI: 10.3390/biomedicines9070710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dos Santos ACM, Dos Santos BRC, Dos Santos BB, de Moura EL, Ferreira JM, Dos Santos LKC, Oliveira SP, Dias RBF, Pereira E Silva AC, de Farias KF, de Souza Figueiredo EVM. Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies. Infect Genet Evol 2021;93:104846. [PMID: 33933633 DOI: 10.1016/j.meegid.2021.104846] [Reference Citation Analysis]
33 Chen F, Zhang Y, Li X, Li W, Liu X, Xue X. The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy. Front Cell Infect Microbiol 2021;11:753721. [PMID: 34746028 DOI: 10.3389/fcimb.2021.753721] [Reference Citation Analysis]
34 Bhandari P, Durrance RJ, Bhuti P, Salama C. Analysis of ABO and Rh Blood Type Association With Acute COVID-19 Infection in Hospitalized Patients: A Superficial Association Among a Multitude of Established Confounders. J Clin Med Res 2020;12:809-15. [PMID: 33447315 DOI: 10.14740/jocmr4382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
35 Karcioglu Batur L, Hekim N. The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate. J Med Virol 2021;93:1409-13. [PMID: 32770768 DOI: 10.1002/jmv.26409] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
36 Davies DA, Adlimoghaddam A, Albensi BC. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease. Mol Neurobiol 2021;58:4178-87. [PMID: 34075562 DOI: 10.1007/s12035-021-02438-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Nimgaonkar I, Valeri L, Susser E, Hussain S, Sunderram J, Aviv A. The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population. Aging (Albany NY) 2021;13:3190-201. [PMID: 33550276 DOI: 10.18632/aging.202639] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Liu Y, Cai J, Wang C, Jin J, Qu L. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 2021;9:1099-1111.e6. [PMID: 33529719 DOI: 10.1016/j.jvsv.2021.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Mariappan V, S R R, Balakrishna Pillai A. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2. IUBMB Life 2020;72:2533-45. [PMID: 33031602 DOI: 10.1002/iub.2391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Yamada D, Ohde S, Imai R, Ikejima K, Matsusako M, Kurihara Y. Visual classification of three computed tomography lung patterns to predict prognosis of COVID-19: a retrospective study. BMC Pulm Med 2022;22:1. [PMID: 34980061 DOI: 10.1186/s12890-021-01813-y] [Reference Citation Analysis]
41 Sarker MT, Hasan AQF, Rafi MO, Hossain MJ, El-mageed HRA, Elsapagh RM, Capasso R, Emran TB. A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention. Biologics 2021;1:357-83. [DOI: 10.3390/biologics1030021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Simsek FI, Colapkulu N, Leblebici IM, Alimoglu O. Another perspective for COVID-19 pandemic: Angiotensin-converting enzyme 2 and ethnicity. North Clin Istanb 2020;7:636-8. [PMID: 33381708 DOI: 10.14744/nci.2020.62144] [Reference Citation Analysis]
43 Di Maria E, Latini A, Borgiani P, Novelli G. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. Hum Genomics 2020;14:30. [PMID: 32917282 DOI: 10.1186/s40246-020-00280-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
44 Riyahi S, Dev H, Behzadi A, Kim J, Attari H, Raza SI, Margolis DJ, Jonisch A, Megahed A, Bamashmos A, Elfatairy K, Prince MR. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study. Radiology 2021;:210777. [PMID: 34254850 DOI: 10.1148/radiol.2021210777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Sarkar A, Sen D, Sharma A, Muttineni RK, Debnath S. Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database. Pharm Chem J 2021;:1-13. [PMID: 34426710 DOI: 10.1007/s11094-021-02441-w] [Reference Citation Analysis]
46 Nasker SS, Nanda A, Ramadass B, Nayak S. Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis. Int J Environ Res Public Health 2021;18:11203. [PMID: 34769722 DOI: 10.3390/ijerph182111203] [Reference Citation Analysis]
47 Mahmood ZS, Fadhil HY, Abdul Hussein TA, Ad'hiah AH. Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients. Meta Gene 2022;:101014. [PMID: 35036327 DOI: 10.1016/j.mgene.2022.101014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Reference Citation Analysis]
49 Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020;11:404. [PMID: 32948252 DOI: 10.1186/s13287-020-01849-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
50 Barash A, Machluf Y, Ariel I, Dekel Y. The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences. Front Med (Lausanne) 2020;7:582793. [PMID: 33195331 DOI: 10.3389/fmed.2020.582793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Mohebbi A, Askari FS, Ebrahimi M, Zakeri M, Yasaghi M, Bagheri H, Javid N. Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2. Future Virology 2020;15:507-14. [DOI: 10.2217/fvl-2020-0160] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Yildirim Z, Sahin OS, Yazar S, Bozok Cetintas V. Genetic and epigenetic factors associated with increased severity of Covid-19. Cell Biol Int 2021;45:1158-74. [PMID: 33590936 DOI: 10.1002/cbin.11572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
53 Redondo N, Navarro D, Aguado JM, Fernández-Ruiz M. Human genetic polymorphisms and risk of viral infection after solid organ transplantation. Transplant Rev (Orlando) 2021;36:100669. [PMID: 34688126 DOI: 10.1016/j.trre.2021.100669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shikov AE, Barbitoff YA, Glotov AS, Danilova MM, Tonyan ZN, Nasykhova YA, Mikhailova AA, Bespalova ON, Kalinin RS, Mirzorustamova AM, Kogan IY, Baranov VS, Chernov AN, Pavlovich DM, Azarenko SV, Fedyakov MA, Tsay VV, Eismont YA, Romanova OV, Hobotnikov DN, Vologzhanin DA, Mosenko SV, Ponomareva TA, Talts YA, Anisenkova AU, Lisovets DG, Sarana AM, Urazov SP, Scherbak SG, Glotov OS. Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome. Front Genet 2020;11:551220. [PMID: 33133145 DOI: 10.3389/fgene.2020.551220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
55 Fawzy MS, Ashour H, Shafie AAA, Dahman NBH, Fares AM, Antar S, Elnoby AS, Fouad FM. The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00309-6] [Reference Citation Analysis]
56 Bagheri-Hosseinabadi Z, Pirsadeghi A, Rahnama A, Bahrehmand F, Abbasifard M. Is there any relationship between serum zinc levels and angiotensin-converting enzyme 2 gene expression in patients with coronavirus disease 2019? Meta Gene 2022;31:100991. [PMID: 34778004 DOI: 10.1016/j.mgene.2021.100991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
57 Devaux CA, Pinault L, Osman IO, Raoult D. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2? Front Public Health 2020;8:608765. [PMID: 33643982 DOI: 10.3389/fpubh.2020.608765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
58 Alaiya A, Alshukairi A, Shinwari Z, Al-Fares M, Alotaibi J, AlOmaim W, Alsharif I, Bakheet R, Alharbi L, Allam R, Asiri A, Memish Z, Alromaih K, Al-Mozaini M. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients. J Inflamm Res 2021;14:4313-28. [PMID: 34511970 DOI: 10.2147/JIR.S322430] [Reference Citation Analysis]
59 Klhůfek J. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero? Acta Clin Belg 2022;77:211-8. [PMID: 32597377 DOI: 10.1080/17843286.2020.1786324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
60 Cai L, Guo X, Cao Y, Ying P, Hong L, Zhang Y, Yi G, Fu M. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review). Int J Mol Med 2021;47:43. [PMID: 33576441 DOI: 10.3892/ijmm.2021.4876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gómez-Carballa A, Rivero-Calle I, Pardo-Seco J, Gómez-Rial J, Rivero-Velasco C, Rodríguez-Núñez N, Barbeito-Castiñeiras G, Pérez-Freixo H, Cebey-López M, Barral-Arca R, Rodriguez-Tenreiro C, Dacosta-Urbieta A, Bello X, Pischedda S, Currás-Tuala MJ, Viz-Lasheras S, Martinón-Torres F, Salas A; GEN-COVID study group. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity. Environ Res 2022;210:112890. [PMID: 35202626 DOI: 10.1016/j.envres.2022.112890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
62 Ahmed FF, Reza MS, Sarker MS, Islam MS, Mosharaf MP, Hasan S, Mollah MNH. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. PLoS One 2022;17:e0266124. [PMID: 35390032 DOI: 10.1371/journal.pone.0266124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Rastegar M, Samadizadeh S, Yasaghi M, Moradi A, Tabarraei A, Salimi V, Tahamtan A. Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking. Arch Virol 2021;166:3117-26. [PMID: 34514519 DOI: 10.1007/s00705-021-05223-7] [Reference Citation Analysis]
64 Escobedo RA, Kaushal D, Singh DK. Insights Into the Changing Landscape of Coronavirus Disease 2019. Front Cell Infect Microbiol 2021;11:761521. [PMID: 35083164 DOI: 10.3389/fcimb.2021.761521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Ribeiro AC, Uehara SCDSA. Systemic arterial hypertension as a risk factor for the severe form of covid-19: scoping review. Rev Saude Publica 2022;56:20. [PMID: 35416846 DOI: 10.11606/s1518-8787.2022056004311] [Reference Citation Analysis]
66 Guilger-Casagrande M, de Barros CT, Antunes VAN, de Araujo DR, Lima R. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability. Front Cell Infect Microbiol 2021;11:598875. [PMID: 33791232 DOI: 10.3389/fcimb.2021.598875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 David S, Dorado G, Duarte EL, David-bosne S, Trigueiro-louro J, Rebelo-de-andrade H. COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity. Immunogenetics. [DOI: 10.1007/s00251-022-01261-w] [Reference Citation Analysis]
68 Kothari A, Singh V, Nath UK, Kumar S, Rai V, Kaushal K, Omar BJ, Pandey A, Jain N. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat? Biology (Basel) 2020;9:E243. [PMID: 32846906 DOI: 10.3390/biology9090243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Borro M, Di Girolamo P, Gentile G, De Luca O, Preissner R, Marcolongo A, Ferracuti S, Simmaco M. Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2. Int J Environ Res Public Health 2020;17:E5573. [PMID: 32748812 DOI: 10.3390/ijerph17155573] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
70 Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, Villani L, Magri F, Latrofa F, Chiovato L. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest 2021;44:1085-90. [PMID: 33025553 DOI: 10.1007/s40618-020-01436-w] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 40.0] [Reference Citation Analysis]
71 Scialo F, Daniele A, Amato F, Pastore L, Matera MG, Cazzola M, Castaldo G, Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung 2020;198:867-77. [PMID: 33170317 DOI: 10.1007/s00408-020-00408-4] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
72 Emami A, Javanmardi F, Akbari A, Kojuri J, Bakhtiari H, Rezaei T, Keshavarzi A, Falahati F. Survival rate in hypertensive patients with COVID-19. Clin Exp Hypertens 2021;43:77-80. [PMID: 32835530 DOI: 10.1080/10641963.2020.1812624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
73 Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacology. 2021;29:91-100. [PMID: 33159646 DOI: 10.1007/s10787-020-00773-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 21.5] [Reference Citation Analysis]
74 Pires de Souza GA, Osman IO, Le Bideau M, Baudoin JP, Jaafar R, Devaux C, La Scola B. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells. Front Cell Infect Microbiol 2021;11:639177. [PMID: 34178717 DOI: 10.3389/fcimb.2021.639177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Sarker J, Das P, Sarker S, Roy AK, Momen AZMR. A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation. Scientifica (Cairo) 2021;2021:2706789. [PMID: 34336361 DOI: 10.1155/2021/2706789] [Reference Citation Analysis]
76 Vivarelli S, Falzone L, Torino F, Scandurra G, Russo G, Bordonaro R, Pappalardo F, Spandidos DA, Raciti G, Libra M. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review). Int J Oncol 2021;58:145-57. [PMID: 33491759 DOI: 10.3892/ijo.2020.5159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
77 Tsuchiya H. Gustatory and Saliva Secretory Dysfunctions in COVID-19 Patients with Zinc Deficiency. Life 2022;12:353. [DOI: 10.3390/life12030353] [Reference Citation Analysis]
78 Tonyan ZN, Nasykhova YA, Danilova MM, Glotov AS. Genetics of macrovascular complications in type 2 diabetes. World J Diabetes 2021; 12(8): 1200-1219 [PMID: 34512887 DOI: 10.4239/wjd.v12.i8.1200] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Torre-Fuentes L, Matías-Guiu J, Hernández-Lorenzo L, Montero-Escribano P, Pytel V, Porta-Etessam J, Gómez-Pinedo U, Matías-Guiu JA. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. J Med Virol 2021;93:863-9. [PMID: 32691890 DOI: 10.1002/jmv.26319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
80 Fang C, Bai S, Chen Q, Zhou Y, Xia L, Qin L, Gong S, Xie X, Zhou C, Tu D, Zhang C, Liu X, Chen W, Bai X, Torr PHS. Deep learning for predicting COVID-19 malignant progression. Med Image Anal 2021;72:102096. [PMID: 34051438 DOI: 10.1016/j.media.2021.102096] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Cai C, Zhang X, Liu Y, Shen E, Feng Z, Guo C, Han Y, Ouyang Y, Shen H. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathog 2021;13:70. [PMID: 34863291 DOI: 10.1186/s13099-021-00466-w] [Reference Citation Analysis]
82 Frutos R, Serra-Cobo J, Pinault L, Lopez Roig M, Devaux CA. Emergence of Bat-Related Betacoronaviruses: Hazard and Risks. Front Microbiol 2021;12:591535. [PMID: 33790874 DOI: 10.3389/fmicb.2021.591535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
83 Al-Karmalawy AA, Dahab MA, Metwaly AM, Elhady SS, Elkaeed EB, Eissa IH, Darwish KM. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front Chem 2021;9:661230. [PMID: 34017819 DOI: 10.3389/fchem.2021.661230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
84 Hussein RK, Elkhair HM. Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. J Mol Struct 2021;1231:129979. [PMID: 33518801 DOI: 10.1016/j.molstruc.2021.129979] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
85 Patil S, Alzahrani KJ, Banjer HJ, Halawani IF, Alzahrani H, Altayar MA, Albogami S, Angeles RF, Hassan AAA, Bhandi S, Raj AT. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2. J Infect Public Health 2022;15:781-7. [PMID: 35738053 DOI: 10.1016/j.jiph.2022.06.004] [Reference Citation Analysis]
86 Meacci E, Garcia-Gil M, Pierucci F. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Int J Mol Sci 2020;21:E6773. [PMID: 32942748 DOI: 10.3390/ijms21186773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
87 Fantini J, Yahi N, Colson P, Chahinian H, La Scola B, Raoult D. The puzzling mutational landscape of the SARS-2-variant Omicron. J Med Virol 2022. [PMID: 34997962 DOI: 10.1002/jmv.27577] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 27.0] [Reference Citation Analysis]
88 Choudhary S, Sreenivasulu K, Mitra P, Misra S, Sharma P. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19. Ann Lab Med 2021;41:129-38. [PMID: 33063674 DOI: 10.3343/alm.2021.41.2.129] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
89 Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Udomsinprasert W. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol 2022;:e2323. [PMID: 34997794 DOI: 10.1002/rmv.2323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Martínez-Sanz J, Jiménez D, Martínez-Campelo L, Cruz R, Vizcarra P, Sánchez-Conde M, Ron R, Rodríguez M, Herrera S, Moreno S, López-Huertas MR, Serrano-Villar S. Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers. Emerg Microbes Infect 2021;10:493-6. [PMID: 33704002 DOI: 10.1080/22221751.2021.1902755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Çolak S, Tekgöz E, Çinar M, Yilmaz G, Tecer D, Biçakçi F, Cuce F, Fidan G, Doğan D, Savaşçi Ü, Arslan Y, Taşçi C, Uyar E, Karacaer Z, Şenkal S, Yilmaz S. Efficacy of tocilizumab in severe COVID-19: a retrospective study. Journal of Health Sciences and Medicine 2022;5:592-9. [DOI: 10.32322/jhsm.1064728] [Reference Citation Analysis]
92 Cardoso EOC, Fine N, Glogauer M, Johnson F, Goldberg M, Golub LM, Tenenbaum HC. The Advent of COVID-19; Periodontal Research Has Identified Therapeutic Targets for Severe Respiratory Disease; an Example of Parallel Biomedical Research Agendas. Front Dent Med 2021;2:674056. [DOI: 10.3389/fdmed.2021.674056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Brandi ML. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? Rev Endocr Metab Disord 2021. [PMID: 34761329 DOI: 10.1007/s11154-021-09692-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Singh U, Hernandez KM, Aronow BJ, Wurtele ES. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep 2021;11:9905. [PMID: 33972602 DOI: 10.1038/s41598-021-89224-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med 2021;23:e3303. [PMID: 33305456 DOI: 10.1002/jgm.3303] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
96 Russo R, Andolfo I, Lasorsa VA, Iolascon A, Capasso M. Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations. Front Genet 2020;11:872. [PMID: 32849840 DOI: 10.3389/fgene.2020.00872] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
97 Nejabi MB, Noor NAS, Raufi N, Essar MY, Ehsan E, Shah J, Shah A, Nemat A. Tongue ulcer in a patient with COVID-19: a case presentation. BMC Oral Health 2021;21:273. [PMID: 34016110 DOI: 10.1186/s12903-021-01635-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Nakazono A, Nakamaru Y, Ramezanpour M, Kondo T, Watanabe M, Hatakeyama S, Kimura S, Honma A, Wormald PJ, Vreugde S, Suzuki M, Homma A. Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells. Front Cell Infect Microbiol 2021;11:655666. [PMID: 33981629 DOI: 10.3389/fcimb.2021.655666] [Reference Citation Analysis]
99 Doroftei B, Ilie OD, Cojocariu RO, Ciobica A, Maftei R, Grab D, Anton E, McKenna J, Dhunna N, Simionescu G. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. Molecules 2020;25:E3323. [PMID: 32707945 DOI: 10.3390/molecules25153323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
100 Gurunathan S, Kang MH, Kim JH. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Front Immunol 2021;12:716407. [PMID: 34394121 DOI: 10.3389/fimmu.2021.716407] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
101 Okendo J, Okanda D. Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00299-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Sharma S. COVID-19: A Concern for Cardiovascular Disease Patients. Cardiovasc Toxicol 2020;20:443-7. [PMID: 32729064 DOI: 10.1007/s12012-020-09596-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 Bhat V, Borse S, Chavan-Gautam P, Joshi K. Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression. J Ayurveda Integr Med 2021. [PMID: 34177193 DOI: 10.1016/j.jaim.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Muralidar S, Gopal G, Visaga Ambi S. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. J Med Virol 2021;93:5260-76. [PMID: 33851732 DOI: 10.1002/jmv.27019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Dehelean L, Papava I, Musat MI, Bondrescu M, Bratosin F, Bucatos BO, Bortun AC, Mager DV, Romosan RS, Romosan AM, Paczeyka R, Cut TG, Pescariu SA, Laza R. Coping Strategies and Stress Related Disorders in Patients with COVID-19. Brain Sci 2021;11:1287. [PMID: 34679351 DOI: 10.3390/brainsci11101287] [Reference Citation Analysis]
106 Beacon TH, Delcuve GP, Davie JR. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1. Genome 2021;64:386-99. [PMID: 33086021 DOI: 10.1139/gen-2020-0124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
107 Di Girolamo P. Assessment of the potential role of atmospheric particulate pollution and airborne transmission in intensifying the first wave pandemic impact of SARS-CoV-2/COVID-19 in Northern Italy. Bull of Atmos Sci & Technol 2020;1:515-50. [DOI: 10.1007/s42865-020-00024-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
108 Akwa TE, Jalloh AA. Is COVID-19 Expanding its Symptom List? The Case of Acute Acro-ischemia and Skin Rash. J CLIN EXP INVEST 2021;12:em00771. [DOI: 10.29333/jcei/10774] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Carvalho KM, Gaunkar RB, Nagarsekar A. Oral cancer management in the SARS-CoV-2 Pandemic-Indian scenario. J Family Med Prim Care 2021;10:1090-4. [PMID: 34041135 DOI: 10.4103/jfmpc.jfmpc_1948_20] [Reference Citation Analysis]
110 Anaeigoudari A, Mollaei HR, Arababadi MK, Nosratabadi R. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System. Inflammation 2021. [PMID: 34524614 DOI: 10.1007/s10753-021-01519-7] [Reference Citation Analysis]
111 Sultan RH, Elesawy BH, Ali TM, Abdallah M, Assal HH, Ahmed AE, Ahmed OM. Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19. Vaccines 2022;10:1106. [DOI: 10.3390/vaccines10071106] [Reference Citation Analysis]
112 Ramos-Rincon JM, Cobos-Palacios L, López-Sampalo A, Ricci M, Rubio-Rivas M, Martos-Pérez F, Lalueza-Blanco A, Moragón-Ledesma S, Fonseca-Aizpuru EM, García-García GM, Beato-Perez JL, Josa-Laorden C, Arnalich-Fernández F, Molinos-Castro S, Torres-Peña JD, Artero A, Vargas-Núñez JA, Mendez-Bailon M, Loureiro-Amigo J, Hernández-Garrido MS, Peris-García J, López-Reboiro ML, Barón-Franco B, Casas-Rojo JM, Gómez-Huelgas R, On Behalf Of The Semi-Covid-Network. Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry. J Clin Med 2022;11:1949. [PMID: 35407557 DOI: 10.3390/jcm11071949] [Reference Citation Analysis]
113 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
114 Renata RN, Arely GA, Gabriela LA, Esther MM. Immunomodulatory Role of Microelements in COVID-19 Outcome: a Relationship with Nutritional Status. Biol Trace Elem Res 2022. [PMID: 35668151 DOI: 10.1007/s12011-022-03290-8] [Reference Citation Analysis]
115 Guijarro C, Pérez-Fernández E, González-Piñeiro B, Meléndez V, Goyanes MJ, Renilla ME, Casas ML, Sastre I, Velasco M; e investigadores COVID Alcorcón., Investigadores COVID Alcorcón (colaboradores). [Differential risk for COVID-19 in the first wave of the disease among Spaniards and migrants from different areas of the world living in Spain]. Rev Clin Esp (Barc) 2021;221:264-73. [PMID: 33250521 DOI: 10.1016/j.rce.2020.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
116 Heegaard PMH, Sturek M, Alloosh M, Belsham GJ. Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig. Front Microbiol 2020;11:573756. [PMID: 33101246 DOI: 10.3389/fmicb.2020.573756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
117 Akhtar S, Benter IF, Danjuma MI, Doi SAR, Hasan SS, Habib AM. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target 2020;28:683-99. [PMID: 32700580 DOI: 10.1080/1061186X.2020.1797754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
118 Patro LPP, Sathyaseelan C, Uttamrao PP, Rathinavelan T. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades. Infect Genet Evol 2021;93:104973. [PMID: 34147651 DOI: 10.1016/j.meegid.2021.104973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Chakraborty S. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity. Biochem Biophys Res Commun 2021;534:374-80. [PMID: 33272568 DOI: 10.1016/j.bbrc.2020.11.075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
120 Calcagnile M, Forgez P, Iannelli A, Bucci C, Alifano M, Alifano P. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Biochimie 2021;180:143-8. [PMID: 33181224 DOI: 10.1016/j.biochi.2020.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
121 Bakhshandeh B, Sorboni SG, Javanmard AR, Mottaghi SS, Mehrabi MR, Sorouri F, Abbasi A, Jahanafrooz Z. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol 2021;90:104773. [PMID: 33607284 DOI: 10.1016/j.meegid.2021.104773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
122 Qi P, Huang M, Li T. Screening the Potential Biomarkers of COVID-19-Related Thrombosis Through Bioinformatics Analysis. Front Genet 2022;13:889348. [DOI: 10.3389/fgene.2022.889348] [Reference Citation Analysis]
123 Gröber U, Holick MF. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients. Int J Vitam Nutr Res 2021;:1-22. [PMID: 33487035 DOI: 10.1024/0300-9831/a000693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
124 Sang ER, Tian Y, Gong Y, Miller LC, Sang Y. Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates. Heliyon 2020;6:e04818. [PMID: 32904785 DOI: 10.1016/j.heliyon.2020.e04818] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
125 Lumpuy-Castillo J, Lorenzo-Almorós A, Pello-Lázaro AM, Sánchez-Ferrer C, Egido J, Tuñón J, Peiró C, Lorenzo Ó. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System. Int J Mol Sci 2020;21:E6471. [PMID: 32899833 DOI: 10.3390/ijms21186471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
126 Jiang X, Li H, Liu Y, Bao L, Zhan L, Gao H, Deng W, Xue J, Liu J, Liu X, Li J, Wang J, Wu S, Yan M, Luo W, Jose PA, Qin C, Yang X, Zhang D, Yang Z. The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice. J Cardiovasc Transl Res 2022. [PMID: 34973134 DOI: 10.1007/s12265-021-10147-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Cafiero C, Rosapepe F, Palmirotta R, Re A, Ottaiano MP, Benincasa G, Perone R, Varriale E, D'Amato G, Cacciamani A, Micera A, Pisconti S. Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study. Pharmgenomics Pers Med 2021;14:621-9. [PMID: 34079337 DOI: 10.2147/PGPM.S303666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Ritter JM, Wilson TM, Gary JM, Seixas JN, Martines RB, Bhatnagar J, Bollweg BC, Lee E, Estetter L, Silva-Flannery L, Bullock HA, Towner JS, Cossaboom CM, Wendling NM, Amman BR, Harvey RR, Taylor D, Rettler H, Barton Behravesh C, Zaki SR. Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US-farmed mink (Neovison vison). Vet Pathol 2022;:3009858221079665. [PMID: 35229669 DOI: 10.1177/03009858221079665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol 2021;101:108255. [PMID: 34688149 DOI: 10.1016/j.intimp.2021.108255] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
130 Cabezón E, Arechaga I. Drug Weaponry to Fight Against SARS-CoV-2. Front Mol Biosci 2020;7:204. [PMID: 33195397 DOI: 10.3389/fmolb.2020.00204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 [DOI: 10.1101/2020.06.14.20131045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
132 Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol 2021. [PMID: 34672376 DOI: 10.1002/jmv.27405] [Reference Citation Analysis]
133 Hosseini NF, Dalirfardouei R, Aliramaei MR, Najafi R. Stem cells or their exosomes: which is preferred in COVID-19 treatment? Biotechnol Lett. [DOI: 10.1007/s10529-021-03209-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Richard D, Muthuirulan P, Aguiar J, Doxey AC, Banerjee A, Mossman K, Hirota J, Capellini TD. Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways. iScience 2022;:104614. [PMID: 35756893 DOI: 10.1016/j.isci.2022.104614] [Reference Citation Analysis]
135 Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int J Mol Sci 2021;22:8255. [PMID: 34361021 DOI: 10.3390/ijms22158255] [Reference Citation Analysis]
136 van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, Sinclair CF, Genden E. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front Endocrinol (Lausanne) 2020;11:565. [PMID: 33013686 DOI: 10.3389/fendo.2020.00565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
137 Poduri R, Joshi G, Jagadeesh G. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Cell Signal 2020;74:109721. [PMID: 32711111 DOI: 10.1016/j.cellsig.2020.109721] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
138 Mir MM, Mir R, Alghamdi MAA, Alsayed BA, Wani JI, Alharthi MH, Al-Shahrani AM. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality. J Pers Med 2021;11:1098. [PMID: 34834450 DOI: 10.3390/jpm11111098] [Reference Citation Analysis]
139 Jaramillo PRM, Simbaña-rivera K, Silva JVV, Gómez-barreno L, Campoverde ABV, Novillo Cevallos JF, Guanoquiza WEA, Guevara SLC, Castro LGI, Puerta NAM, Guayta Valladares AW, Lister A, Ortiz-prado E. High-Altitude Is Associated with Better Short-Term Survival in Critically Ill COVID-19 Patients Admitted to the ICU. SSRN Journal. [DOI: 10.2139/ssrn.3756820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Yan YY, Zhou WM, Wang YQ, Guo QR, Zhao FX, Zhu ZY, Xing YX, Zhang HY, Aljofan M, Jarrahi AM, Makabel B, Zhang JY. The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge. Front Mol Biosci 2021;8:699929. [PMID: 34368228 DOI: 10.3389/fmolb.2021.699929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Guimarães LMF, Rossini CVT, Lameu C. Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems. Nitric Oxide 2021;111-112:64-71. [PMID: 33831567 DOI: 10.1016/j.niox.2021.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
142 Ali N, Fariha KA, Islam F, Mohanto NC, Ahmad I, Hosen MJ, Ahmed S. Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: A retrospective study in the Asian and European population. J Med Virol 2021;93:4326-33. [PMID: 33710631 DOI: 10.1002/jmv.26932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Frutos R, Pliez O, Gavotte L, Devaux CA. There is no "origin" to SARS-CoV-2. Environ Res 2021;:112173. [PMID: 34626592 DOI: 10.1016/j.envres.2021.112173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
144 Papadimitriou DT, Vassaras AK, Holick MF. Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach. World J Virol 2021; 10(3): 111-129 [PMID: 34079693 DOI: 10.5501/wjv.v10.i3.111] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
145 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 De Donno A, Lobreglio G, Panico A, Grassi T, Bagordo F, Bozzetti MP, Massari S, Siculella L, Damiano F, Guerra F, Greco M, Chicone M, Lazzari R, Alifano P. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection. Int J Environ Res Public Health 2021;18:1318. [PMID: 33535692 DOI: 10.3390/ijerph18031318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
147 Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol 2020;16:1159-84. [PMID: 33356661 DOI: 10.1080/1744666X.2021.1847640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
148 Lipoldová M, Demant P. Gene-Specific Sex Effects on Susceptibility to Infectious Diseases. Front Immunol 2021;12:712688. [PMID: 34721380 DOI: 10.3389/fimmu.2021.712688] [Reference Citation Analysis]
149 Chaudhary M. COVID-19 susceptibility: potential of ACE2 polymorphisms. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00099-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
150 Fenollar F, Mediannikov O, Maurin M, Devaux C, Colson P, Levasseur A, Fournier PE, Raoult D. Mink, SARS-CoV-2, and the Human-Animal Interface. Front Microbiol 2021;12:663815. [PMID: 33868218 DOI: 10.3389/fmicb.2021.663815] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
151 Softa A, Bahl S, Bagha AK, Sehgal S, Haleem A, Javaid M. Tissue Engineering and its Significance in Healthcare During COVID-19 Pandemic: Potential Applications and Perspectives. J Ind Intg Mgmt 2021;06:221-33. [DOI: 10.1142/s242486222150007x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
152 Alosaimi B, Naeem A, Hamed ME, Alkadi HS, Alanazi T, Al Rehily SS, Almutairi AZ, Zafar A. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J 2021;18:127. [PMID: 34127006 DOI: 10.1186/s12985-021-01594-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
153 Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res 2021;26:84. [PMID: 34344463 DOI: 10.1186/s40001-021-00563-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
154 Lima RS, Rocha LPC, Moreira PR. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19. Cell Biochem Funct 2021;39:713-26. [PMID: 34075603 DOI: 10.1002/cbf.3648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Lobiuc A, Dimian M, Gheorghita R, Sturdza OAC, Covasa M. Introduction and Characteristics of SARS-CoV-2 in North-East of Romania During the First COVID-19 Outbreak. Front Microbiol 2021;12:654417. [PMID: 34305826 DOI: 10.3389/fmicb.2021.654417] [Reference Citation Analysis]
156 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
157 Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (Lausanne) 2021;8:663708. [PMID: 34552938 DOI: 10.3389/fmed.2021.663708] [Reference Citation Analysis]
158 Smarz-Widelska I, Grywalska E, Morawska I, Forma A, Michalski A, Mertowski S, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Korona-Glowniak I, Parczewski M, Załuska W. Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives. Int J Mol Sci 2021;22:7082. [PMID: 34209289 DOI: 10.3390/ijms22137082] [Reference Citation Analysis]
159 Hassanpour M, Rezaie J, Nouri M, Panahi Y. The role of extracellular vesicles in COVID-19 virus infection. Infect Genet Evol 2020;85:104422. [PMID: 32544615 DOI: 10.1016/j.meegid.2020.104422] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
160 Kerboua KE. The perplexing question of trained immunity vs adaptive memory in COVID‐19. J Med Virol 2020;92:1858-63. [DOI: 10.1002/jmv.26083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
161 Baildya N, Ghosh NN, Chattopadhyay AP. Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies. J Mol Struct 2021;1230:129891. [PMID: 33518803 DOI: 10.1016/j.molstruc.2021.129891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
162 Li G, Zhang L, Du N. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV. Genes Genomics 2021. [PMID: 34228320 DOI: 10.1007/s13258-021-01136-6] [Reference Citation Analysis]
163 Saih A, Baba H, Bouqdayr M, Ghazal H, Hamdi S, Kettani A, Wakrim L. In Silico Analysis of High-Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS-CoV-2 Infection. Biomed Res Int 2021;2021:6685840. [PMID: 33884270 DOI: 10.1155/2021/6685840] [Reference Citation Analysis]
164 Lio D, Scola L, Giarratana RM, Candore G, Colonna-Romano G, Caruso C, Balistreri CR. SARS CoV2 infection _The longevity study perspectives. Ageing Res Rev 2021;67:101299. [PMID: 33607290 DOI: 10.1016/j.arr.2021.101299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
165 Tarek M, Abdelzaher H, Kobeissy F, El-Fawal HAN, Salama MM, Abdelnaser A. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2. Genes (Basel) 2021;12:1041. [PMID: 34356057 DOI: 10.3390/genes12071041] [Reference Citation Analysis]
166 Lalaoui R, Bakour S, Raoult D, Verger P, Sokhna C, Devaux C, Pradines B, Rolain JM. What could explain the late emergence of COVID-19 in Africa? New Microbes New Infect 2020;38:100760. [PMID: 32983542 DOI: 10.1016/j.nmni.2020.100760] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
167 Oyagbemi AA, Ajibade TO, Aboua YG, Gbadamosi IT, Adedapo ADA, Aro AO, Adejumobi OA, Thamahane-Katengua E, Omobowale TO, Falayi OO, Oyagbemi TO, Ogunpolu BS, Hassan FO, Ogunmiluyi IO, Ola-Davies OE, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Yakubu MA, Oguntibeju OO. The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19. Vet World 2021;14:2705-13. [PMID: 34903929 DOI: 10.14202/vetworld.2021.2705-2713] [Reference Citation Analysis]
168 Ercegovac M, Asanin M, Savic-radojevic A, Ranin J, Matic M, Djukic T, Coric V, Jerotic D, Todorovic N, Milosevic I, Stevanovic G, Simic T, Bukumiric Z, Pljesa-ercegovac M. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants 2022;11:954. [DOI: 10.3390/antiox11050954] [Reference Citation Analysis]
169 Osman IO, Melenotte C, Brouqui P, Million M, Lagier JC, Parola P, Stein A, La Scola B, Meddeb L, Mege JL, Raoult D, Devaux CA. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol 2021;12:625732. [PMID: 34194422 DOI: 10.3389/fimmu.2021.625732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Kelleni MT. SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality. J Infect 2021;82:e35. [PMID: 32810520 DOI: 10.1016/j.jinf.2020.08.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
171 Rajput SK, Logsdon DM, Kile B, Engelhorn HJ, Goheen B, Khan S, Swain J, McCormick S, Schoolcraft WB, Yuan Y, Krisher RL. Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection. F S Sci 2021;2:33-42. [PMID: 33521687 DOI: 10.1016/j.xfss.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
172 Sheng WH, Liu WD, Wang JT, Chang SY, Chang SC. Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. J Formos Med Assoc 2021;120:311-7. [PMID: 33139151 DOI: 10.1016/j.jfma.2020.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Jothimani D, Kailasam E, Danielraj S, Nallathambi B, Ramachandran H, Sekar P, Manoharan S, Ramani V, Narasimhan G, Kaliamoorthy I, Rela M. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis 2020;100:343-9. [PMID: 32920234 DOI: 10.1016/j.ijid.2020.09.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 27.5] [Reference Citation Analysis]
174 Deng H, Yan X, Yuan L. Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 2021;6:344. [PMID: 34545062 DOI: 10.1038/s41392-021-00736-8] [Reference Citation Analysis]
175 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Hadi-Alijanvand H, Rouhani M. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes. J Proteome Res 2020;19:4609-23. [PMID: 32786692 DOI: 10.1021/acs.jproteome.0c00348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
177 Oh TK, Cho HW, Suh JW, Song IA. Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea. Yonsei Med J 2021;62:577-83. [PMID: 34164954 DOI: 10.3349/ymj.2021.62.7.577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Chakraborty C, Bhattacharya M, Mallick B, Sharma AR, Lee SS, Agoramoorthy G. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol 2021;14:225-38. [PMID: 33423554 DOI: 10.1080/17512433.2021.1874348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
179 Sharov KS. Adaptation of a Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data. Int J Antimicrob Agents 2020;56:106093. [PMID: 32653618 DOI: 10.1016/j.ijantimicag.2020.106093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
180 Wiese O, Zemlin AE, Pillay TS. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2). J Clin Pathol 2021;74:285-90. [PMID: 32759311 DOI: 10.1136/jclinpath-2020-206954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
181 Franczyk B, Rysz J, Miłoński J, Konecki T, Rysz-Górzyńska M, Gluba-Brzózka A. Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? Pharmaceuticals (Basel) 2022;15:739. [PMID: 35745658 DOI: 10.3390/ph15060739] [Reference Citation Analysis]
182 Aleksova A, Gagno G, Sinagra G, Beltrami AP, Janjusevic M, Ippolito G, Zumla A, Fluca AL, Ferro F. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci 2021;22:4526. [PMID: 33926110 DOI: 10.3390/ijms22094526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
183 Norman FF, Crespillo-Andújar C, Pérez-Molina JA, Comeche B, Chamorro S, Monge-Maillo B, Moreno-Guillén S, López-Vélez R; COVID-19 ID Team. COVID-19 and geographical area of origin. Clin Microbiol Infect 2021;27:632.e1-5. [PMID: 33246039 DOI: 10.1016/j.cmi.2020.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Cosentino M, Ferrari M, Marino F. Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals. J Neuroimmune Pharmacol 2021;16:517-8. [PMID: 34003413 DOI: 10.1007/s11481-021-09998-z] [Reference Citation Analysis]
185 Villapalos-García G, Zubiaur P, Rivas-Durán R, Campos-Norte P, Arévalo-Román C, Fernández-Rico M, García-Fraile Fraile L, Fernández-Campos P, Soria-Chacartegui P, Fernández de Córdoba-Oñate S, Delgado-Wicke P, Fernández-Ruiz E, González-Álvaro I, Sanz J, Abad-Santos F, de Los Santos I. Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life Sci Alliance 2022;5:e202201396. [PMID: 35636966 DOI: 10.26508/lsa.202201396] [Reference Citation Analysis]
186 Shoily SS, Ahsan T, Fatema K, Sajib AA. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Infect Genet Evol 2021;92:104888. [PMID: 33933634 DOI: 10.1016/j.meegid.2021.104888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol 2021;12:593223. [PMID: 33584343 DOI: 10.3389/fphys.2021.593223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
188 Li H, He J, Bao W, Wang P, Lv Y, Xu C, Hu P, Gao Y, Zheng S, An J, Deng G, Dong J. Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests. Bioanalysis 2021;13:77-88. [PMID: 33427483 DOI: 10.4155/bio-2020-0219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Yamasaki H. Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19. Nitric Oxide 2020;103:29-30. [PMID: 32712272 DOI: 10.1016/j.niox.2020.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
190 Acherjee T, Behara A, Saad M, Vittorio TJ. Mechanisms and management of prothrombotic state in COVID-19 disease. Ther Adv Cardiovasc Dis 2021;15:17539447211053470. [PMID: 34693818 DOI: 10.1177/17539447211053470] [Reference Citation Analysis]
191 Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021;6:317. [PMID: 34446699 DOI: 10.1038/s41392-021-00733-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
192 Gómez J, Albaiceta GM, García-Clemente M, López-Larrea C, Amado-Rodríguez L, Lopez-Alonso I, Hermida T, Enriquez AI, Herrero P, Melón S, Alvarez-Argüelles ME, Boga JA, Rojo-Alba S, Cuesta-Llavona E, Alvarez V, Lorca R, Coto E. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene 2020;762:145102. [PMID: 32882331 DOI: 10.1016/j.gene.2020.145102] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
193 Qi X, Kong H, Ding W, Wu C, Ji N, Huang M, Li T, Wang X, Wen J, Wu W, Wu M, Huang C, Li Y, Liu Y, Tang J. Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation. Front Med (Lausanne) 2021;8:638194. [PMID: 34222271 DOI: 10.3389/fmed.2021.638194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Castiglione GM, Zhou L, Xu Z, Neiman Z, Hung C, Duh EJ, Hejnol A. Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2. PLoS Biol 2021;19:e3001510. [DOI: 10.1371/journal.pbio.3001510] [Reference Citation Analysis]
195 Pattaro C, Barbieri G, Foco L, Weichenberger CX, Biasiotto R, De Grandi A, Fuchsberger C, Egger C, Amon VSC, Hicks AA, Mian M, Mahlknecht A, Lombardo S, Meier H, Weiss H, Rainer R, Dejaco C, Weiss G, Lavezzo E, Crisanti A, Pizzato M, Domingues FS, Mascalzoni D, Gögele M, Melotti R, Pramstaller PP. Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol. Pathog Glob Health 2021;:1-9. [PMID: 34637685 DOI: 10.1080/20477724.2021.1978225] [Reference Citation Analysis]
196 Das S, K R A, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Life Sci 2020;258:118202. [PMID: 32758625 DOI: 10.1016/j.lfs.2020.118202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
197 Georgas A, Lampas E, Houhoula D, Skoufias A, Patsilinakos S, Tsafaridis I, Patrinos G, Adamopoulos N, Ferraro A, Hristoforou E. ACE2-based capacitance sensor for rapid native SARS-CoV-2 detection in biological fluids and its correlation with real-time PCR. Biosensors and Bioelectronics 2022;202:114021. [DOI: 10.1016/j.bios.2022.114021] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
198 Chakraborty S. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity. Biochem Biophys Res Commun 2021;538:97-103. [PMID: 33602511 DOI: 10.1016/j.bbrc.2021.01.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
199 Kelleni MT. ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror. Inflammopharmacology 2020;28:1477-80. [PMID: 32920716 DOI: 10.1007/s10787-020-00755-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
200 Coperchini F, Chiovato L, Rotondi M. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One! Front Immunol 2021;12:668507. [PMID: 33981314 DOI: 10.3389/fimmu.2021.668507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
201 Singh S, Kola P, Kaur D, Singla G, Mishra V, Panesar PS, Mallikarjunan K, Krishania M. Therapeutic Potential of Nutraceuticals and Dietary Supplements in the Prevention of Viral Diseases: A Review. Front Nutr 2021;8:679312. [PMID: 34604272 DOI: 10.3389/fnut.2021.679312] [Reference Citation Analysis]
202 Rahim F, Amin S, Bahadur S, Noor M, Mahmood A, Gul H. ABO / Rh-D Blood types and susceptibility to Corona Virus Disease-19 in Peshawar, Pakistan. Pak J Med Sci 2021;37:4-8. [PMID: 33437242 DOI: 10.12669/pjms.37.1.3655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
203 Abolaban FA, Djouider FM. Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development. Open Life Sci 2021;16:558-70. [PMID: 34131589 DOI: 10.1515/biol-2021-0051] [Reference Citation Analysis]
204 Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology 2021;29:939-63. [PMID: 33822324 DOI: 10.1007/s10787-021-00806-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
205 Chaouat AE, Achdout H, Kol I, Berhani O, Roi G, Vitner EB, Melamed S, Politi B, Zahavy E, Brizic I, Lenac Rovis T, Alfi O, Wolf D, Jonjic S, Israely T, Mandelboim O. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. PLoS Pathog 2021;17:e1010175. [PMID: 34929007 DOI: 10.1371/journal.ppat.1010175] [Reference Citation Analysis]
206 Maiese A, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Frati P, Fineschi V. Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol. 2020;. [PMID: 33026628 DOI: 10.1007/s12024-020-00310-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 21.5] [Reference Citation Analysis]
207 Chi H, Chiu NC, Tai YL, Chang HY, Lin CH, Sung YH, Tseng CY, Liu LY, Lin CY. Clinical features of neonates born to mothers with coronavirus disease-2019: A systematic review of 105 neonates. J Microbiol Immunol Infect 2021;54:69-76. [PMID: 32847748 DOI: 10.1016/j.jmii.2020.07.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
208 Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics 2021;11:731-53. [PMID: 33391502 DOI: 10.7150/thno.51471] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 24.0] [Reference Citation Analysis]
209 Arshad AR, Bashir I, Ijaz F, Loh N, Shukla S, Rehman UU, Aftab RK. Is COVID-19 Fatality Rate Associated with Malaria Endemicity? Discoveries (Craiova) 2020;8:e120. [PMID: 33365386 DOI: 10.15190/d.2020.17] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Zipeto D, Palmeira JDF, Argañaraz GA, Argañaraz ER. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.Front Immunol. 2020;11:576745. [PMID: 33117379 DOI: 10.3389/fimmu.2020.576745] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
211 El Baba R, Herbein G. Management of epigenomic networks entailed in coronavirus infections and COVID-19. Clin Epigenetics 2020;12:118. [PMID: 32758273 DOI: 10.1186/s13148-020-00912-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
212 Zhan Y, Ta W, Tang W, Hua R, Wang J, Wang C, Lu W. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. Drug Dev Res 2021. [PMID: 33847382 DOI: 10.1002/ddr.21815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
213 Mobini Kesheh M, Shavandi S, Hosseini P, Kakavand-Ghalehnoei R, Keyvani H. Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions. Biomed Res Int 2021;2021:6693909. [PMID: 34136572 DOI: 10.1155/2021/6693909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Bhuiyan FR, Howlader S, Raihan T, Hasan M. Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic. Front Med (Lausanne) 2020;7:444. [PMID: 32850918 DOI: 10.3389/fmed.2020.00444] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
215 Bloch MJ. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent? J Am Coll Cardiol 2020;76:277-9. [PMID: 32674791 DOI: 10.1016/j.jacc.2020.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
216 Altiok D, Savci EZ, Özkara B, Alkan K, Namdar DS, Tunçer G, Kilinç BR, Suiçmez E, Çetin G, Ünal S, Dönmüş B, Karagülleoğlu ZY, Uncuoğlu DB, Tekeli C, Mendi HA, Bengi VU, Cengiz Seval G, Kiliç P, Güneş Altuntaş E, Demir-Dora D. Host variations in SARS-CoV-2 infection. Turk J Biol 2021;45:404-24. [PMID: 34803443 DOI: 10.3906/biy-2104-67] [Reference Citation Analysis]
217 Lechien JR, Hsieh J, Barillari MR, Cammaroto G, Hans S, Chiesa-Estomba CM, Saussez S. Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol 2020;277:2393-4. [PMID: 32494948 DOI: 10.1007/s00405-020-06083-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Kamyshnyi A, Krynytska I, Matskevych V, Marushchak M, Lushchak O. Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology. Int J Hypertens 2020;2020:8019360. [PMID: 33489355 DOI: 10.1155/2020/8019360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
219 Ghazy RM, Almaghraby A, Shaaban R, Kamal A, Beshir H, Moursi A, Ramadan A, Taha SHN. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Sci Rep. 2020;10:22139. [PMID: 33335141 DOI: 10.1038/s41598-020-77748-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
220 SeyedAlinaghi S, Mehrtak M, MohsseniPour M, Mirzapour P, Barzegary A, Habibi P, Moradmand-Badie B, Afsahi AM, Karimi A, Heydari M, Mehraeen E, Dadras O, Sabatier JM, Voltarelli F. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur J Med Res 2021;26:46. [PMID: 34016183 DOI: 10.1186/s40001-021-00516-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
221 Zhang Y, Yang H, Li S, Li WD, Wang J, Wang Y. Association analysis framework of genetic and exposure risks for COVID-19 in middle-aged and elderly adults. Mech Ageing Dev 2021;194:111433. [PMID: 33444631 DOI: 10.1016/j.mad.2021.111433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
222 Deffner F, Scharr M, Klingenstein S, Klingenstein M, Milazzo A, Scherer S, Wagner A, Hirt B, Mack AF, Neckel PH. Histological Evidence for the Enteric Nervous System and the Choroid Plexus as Alternative Routes of Neuroinvasion by SARS-CoV2. Front Neuroanat 2020;14:596439. [PMID: 33122999 DOI: 10.3389/fnana.2020.596439] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
223 de Melo BAG, Benincasa JC, Cruz EM, Maricato JT, Porcionatto MA. 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting. Biomed J 2021;44:31-42. [PMID: 33602633 DOI: 10.1016/j.bj.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
224 Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K. Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development. Hum Vaccin Immunother 2020;16:2992-3000. [PMID: 32755425 DOI: 10.1080/21645515.2020.1787068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
225 Toprani SM, Scheibler C, Nagel ZD. Interplay Between Air Travel, Genome Integrity, and COVID-19 Risk vis-a-vis Flight Crew. Front Public Health 2020;8:590412. [PMID: 33392133 DOI: 10.3389/fpubh.2020.590412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Chetboul V, Foulex P, Kartout K, Klein AM, Sailleau C, Dumarest M, Delaplace M, Gouilh MA, Mortier J, Le Poder S. Myocarditis and Subclinical-Like Infection Associated With SARS-CoV-2 in Two Cats Living in the Same Household in France: A Case Report With Literature Review. Front Vet Sci 2021;8:748869. [PMID: 34746286 DOI: 10.3389/fvets.2021.748869] [Reference Citation Analysis]
227 Ilie OD, Ciobica A, Doroftei B. Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate. Medicina (Kaunas) 2020;56:E566. [PMID: 33121072 DOI: 10.3390/medicina56110566] [Reference Citation Analysis]
228 Alshukry A, Ali H, Ali Y, Al-Taweel T, Abu-Farha M, AbuBaker J, Devarajan S, Dashti AA, Bandar A, Taleb H, Al Bader A, Aly NY, Al-Ozairi E, Al-Mulla F, Bu Abbas M. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. PLoS One 2020;15:e0242768. [PMID: 33216801 DOI: 10.1371/journal.pone.0242768] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
229 Laurini E, Marson D, Aulic S, Fermeglia A, Pricl S. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence. ACS Nano 2021;15:6929-48. [PMID: 33733740 DOI: 10.1021/acsnano.0c10833] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]